The Ensign Group, Inc. (NASDAQ: ENSG) is a prominent player in the healthcare sector, focusing on skilled nursing, senior living services, and various healthcare therapies. As a company listed on the NASDAQ, Ensign is preparing to release its quarterly earnings on February 5, 2025. Wall Street anticipates earnings per share (EPS) of $1.47 and revenue of approximately $1.13 billion.
Ensign's financial metrics provide a deeper understanding of its market position. The company has a price-to-earnings (P/E) ratio of 34.14, which indicates how much investors are willing to pay for each dollar of earnings. This ratio suggests that the market has a positive outlook on Ensign's future earnings potential. The price-to-sales ratio of 2.03 further reflects the company's market value relative to its sales.
The enterprise value to sales ratio of 2.39 highlights Ensign's total valuation compared to its revenue. This metric is crucial for understanding how the market values the company's overall operations. Additionally, the enterprise value to operating cash flow ratio of 29.38 shows the company's valuation in relation to its cash flow from operations, an important indicator of financial health.
Ensign's earnings yield stands at 2.93%, offering insight into the earnings generated per dollar invested. This yield is a useful measure for investors assessing the potential return on their investment. The debt-to-equity ratio of 1.15 indicates the proportion of debt used to finance the company's assets relative to shareholders' equity, suggesting a balanced approach to leveraging.
Lastly, the current ratio of 1.56 suggests that Ensign is well-positioned to cover its short-term liabilities with its short-term assets. This ratio is a key indicator of the company's liquidity and ability to meet its financial obligations in the near term. As Ensign prepares to discuss its performance in the upcoming webcast, these financial metrics provide a comprehensive view of its market standing.
Read More